We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$112B
AUM Growth
+$1.24B
Cap. Flow
-$4.67B
Cap. Flow %
-4.16%
Top 10 Hldgs %
33.05%
Holding
7,587
New
332
Increased
2,155
Reduced
4,171
Closed
298

Sector Composition

Rank Sector Weight
1 Financials 4.53%
2 Energy 3.9%
3 Technology 3.29%
4 Healthcare 2.41%
5 Industrials 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XIFR
5576
XPLR Infrastructure LP
XIFR
$1.04B
$51K ﹤0.01%
1,548
+613
+66% +$18.6K
ATSG
5577
DELISTED
Air Transport Services Group
ATSG
$51K ﹤0.01%
3,203
-47,072
-94% -$767K
INFN
5578
DELISTED
Infinera Corporation Common Stock
INFN
$51K ﹤0.01%
4,971
-142,303
-97% -$1.43M
BCRX icon
5579
PUT
BioCryst Pharmaceuticals
BCRX
$2.42B
$50K ﹤0.01%
5,900
-400
-6% -$2.78K
CSM icon
5580
ProShares Large Cap Core Plus
CSM
$506M
$50K ﹤0.01%
1,728
DSGR icon
5581
Distribution Solutions Group
DSGR
$1.6B
$50K ﹤0.01%
4,484
-8,220
-65% -$102K
GDV icon
5582
Gabelli Dividend & Income Trust
GDV
$2.59B
$50K ﹤0.01%
2,415
-4,785
-66% -$98.8K
IGHG icon
5583
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
$50K ﹤0.01%
662
LTPZ icon
5584
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$693M
$50K ﹤0.01%
756
-62
-8% -$4.08K
PSEC icon
5585
CALL
Prospect Capital
PSEC
$1.08B
$50K ﹤0.01%
5,500
+1,200
+28% +$10.8K
TDOC icon
5586
Teladoc Health
TDOC
$1.66B
$50K ﹤0.01%
2,023
-16,882
-89% -$351K
TDW icon
5587
Tidewater
TDW
$3.63B
$50K ﹤0.01%
1,352
-395
-23% -$22.4K
WFC.PRL icon
5588
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.68B
$50K ﹤0.01%
40
-8,795
-100% -$10.7M
CTR
5589
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$50K ﹤0.01%
735
-14,442
-95% -$967K
SIEN
5590
DELISTED
Sientra, Inc.
SIEN
$50K ﹤0.01%
599
MNTA
5591
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$50K ﹤0.01%
3,782
-183,298
-98% -$2.87M
JMEI
5592
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$50K ﹤0.01%
1,355
+57
+4% +$2.37K
NXTM
5593
DELISTED
NxStage Medical Inc.
NXTM
$50K ﹤0.01%
1,878
-58,223
-97% -$1.61M
YUME
5594
DELISTED
YuMe, Inc.
YUME
$50K ﹤0.01%
12,200
ARNC.PRB
5595
DELISTED
Arconic Inc.
ARNC.PRB
$50K ﹤0.01%
1,220
CVCO icon
5596
Cavco Industries
CVCO
$4.36B
$49K ﹤0.01%
417
-3,666
-90% -$398K
DBAW icon
5597
Xtrackers MSCI All World ex US Hedged Equity ETF
DBAW
$282M
$49K ﹤0.01%
1,938
-16
-0.8% -$399
HBNC icon
5598
Horizon Bancorp
HBNC
$1.06B
$49K ﹤0.01%
2,789
-28,594
-91% -$497K
PTCT icon
5599
CALL
PTC Therapeutics
PTCT
$6.18B
$49K ﹤0.01%
5,000
-10,400
-68% -$126K
RGNX icon
5600
Regenxbio
RGNX
$616M
$49K ﹤0.01%
2,568
-19,626
-88% -$379K

Similar funds

Citigroup's Q1 2017 Portfolio in Review

As of Q1 2017, Citigroup held 7,587 positions worth $112B, up 1.1% from $111B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Citigroup withdrew a net $4.67B in Q1 2017, closing 298 positions and reducing 4,171 holdings. Its most notable exit was St Jude Medical, an estimated $368M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.5% of assets, down from 5% a quarter earlier, followed by Energy and Technology.

Against the trend, Citigroup opened a new position in Kayne Anderson Acquisition Corp. Unit worth $25.1M.

  • Citigroup's largest Q1 2017 buy was Kayne Anderson Acquisition Corp. Unit: 2,500,000 shares worth $25.1M.
  • Citigroup added most to Walt Disney in Q1 2017, an estimated $358M increase.
  • Citigroup's biggest Q1 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.61B.
  • Citigroup fully exited St Jude Medical in Q1 2017, selling an estimated $368M.
  • Citigroup's ten largest holdings make up 33% of its $112B portfolio in Q1 2017.
  • Citigroup opened 332 new positions and closed 298 in Q1 2017.
  • Citigroup's portfolio value rose 1.1% quarter-over-quarter to $112B.

Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.